New Treatments vs Screening in Reducing Breast Cancer Deaths New Treatments vs Screening in Reducing Breast Cancer Deaths
Improvements in breast cancer screening and novel treatments have contributed to breast cancer mortality reductions in recent years, although the impact varies by disease subtype, say US scientists.Medscape Medical News
New J. Chem., 2018, Advance Article DOI: 10.1039/C8NJ01713A, PaperTania Lozano-Cruz, Rafael Gomez, F. Javier de la Mata, Paula Ortega A water soluble "bow-tie" cationic carbosilane dendrimer with curcumin in the core displays antioxidant and antitumoral activities against breast cancer cells. To cite this article before page numbers are assigned, use the DOI form of citation above. The content of this RSS Feed (c) The Royal Society of Chemistry
Abstract Transfeminine individuals are treated with estradiol and anti-androgen agents to transition to a more feminine appearance. The physical changes that occur with estradiol therapy include breast development, body fat redistribution, and decreased muscle mass. Transfeminine treatment regimens require monitoring and dose adjustments to achieve appropriate physiologic targets to enhance feminization and decrease risk of adverse outcomes. Adverse effects associated with estradiol use include thromboembolic disease, macroprolactinoma, breast cancer, coronary artery disease, cerebrovascular disease, cholelithiasi...
Buried in a new N.I.H. report are disturbing examples of coordination between scientists and the alcohol industry on a study that could have changed America ’ s drinking habits.
Researchers have developed a quicker, better and cheaper way than mammograms to detect breast cancer: a laser scanner that can find tumors in 15 seconds.
Conditions: Breast Cancer; HR+/HER2-negative Breast Cancer; Metastasis Intervention: Drug: Fulvestrant + palbociclib Sponsor: Assistance Publique - Hôpitaux de Paris Not yet recruiting
Condition: Breast Cancer Interventions: Drug: ZN-c5; Drug: Palbociclib Sponsor: Zeno Alpha Inc. Not yet recruiting
Condition: Breast Cancer, Invasive Ductal Intervention: Device: Philips Sonalleve® MR-HIFU Breast Therapy System Sponsor: Kantonsspital Winterthur KSW Not yet recruiting
CONCLUSIONS: It was found that most patients diagnosed with breast cancer showed dermatologic manifestations during the proposed cancer treatment. Patients undergoing radiotherapy and surgery showed skin changes with greater statistical significance.
We report the case of a 65-year-old woman with cutaneous metastasis from breast cancer treated 14 years back, manifested by extensive firm and infiltrated red-purple plaques on the sides of the trunk, with a course of six months. After evaluation, she was referred to the regional cancer center. She passed away one month and a half later.
Conclusion: In this study, PABC showed lower expression of ER/PR, higher overexpression of HER2, fewer luminal A subtype, and more TNBC subtype compared to YBC. PABC had worse BCSS, especially luminal B subtype, compared to YBC.Oncology